RDTCF (Rapid Dose Therapeutics) EPS (Basic) : $-0.03 (TTM As of Nov. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics EPS (Basic)?

Rapid Dose Therapeutics's basic earnings per share (Basic EPS) for the three months ended in Nov. 2024 was $-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Nov. 2024 was $-0.03.

Rapid Dose Therapeutics's EPS (Diluted) for the three months ended in Nov. 2024 was $-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Nov. 2024 was $-0.03.

Rapid Dose Therapeutics's EPS without NRI for the three months ended in Nov. 2024 was $-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Nov. 2024 was -0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Rapid Dose Therapeutics EPS (Basic) Historical Data

The historical data trend for Rapid Dose Therapeutics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics EPS (Basic) Chart

Rapid Dose Therapeutics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

EPS (Basic)

Get a 7-Day Free Trial

-0.08

-0.02

-0.06

-0.03

Rapid Dose Therapeutics Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
EPS (Basic)	Get a 7-Day Free Trial															-0.01	-0.01	-0.01	-0.01	-0.01

Rapid Dose Therapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Rapid Dose Therapeutics's Basic EPS for the fiscal year that ended in Feb. 2024 is calculated as

Basic EPS (A: Feb. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-3.19	-	0)	/	104.964
	=	-0.03

Rapid Dose Therapeutics's Basic EPS for the quarter that ended in Nov. 2024 is calculated as

Basic EPS (Q: Nov. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.976	-	0)	/	124.174
	=	-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03

Rapid Dose Therapeutics (OTCPK:RDTCF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Rapid Dose Therapeutics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

DOSE:Canada

Address

1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4

Website

https://www.rapid-dose.com

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.